COMMUNIQUÉS West-GlobeNewswire

Rubius Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference

27/12/2018 - 22:05

CAMBRIDGE, Mass., Dec. 27, 2018 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq: RUBY), a biotechnology company developing an entirely new class of allogeneic cellular therapies, announced today that Pablo J. [...]

iCAD Announces CFO Transition

27/12/2018 - 22:01

NASHUA, N.H., Dec. 27, 2018 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology company providing innovative cancer detection and therapy solutions, today announced that Richard Christopher, [...]

Tauriga Sciences Inc. Selects Name & Logo Under Which it will Brand its Cannabis Infused Chewing Gum Product Line

27/12/2018 - 21:41

New York, NY, Dec. 27, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. ( TAUG ) (“Tauriga” or the “Company”), engaged in building its business through the development, distribution, and licensing of [...]

Golden Leaf Holdings Ltd. Hires New CEO/President

27/12/2018 - 20:28

TORONTO, Dec. 27, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (CSE: GLH) (OTCQB: GLDFF) (“Golden Leaf” of the “Company”), a cannabis company with cultivation, production and retail operations built around [...]

Rheumatology Community Urges CMS to Proceed with Caution When Considering IPI Drug Pricing Model

27/12/2018 - 20:16

ACR Recommends CMS Make Drug Pricing Demonstration Voluntary; Better Address Financial and Administrative Challenges for Providers to Protect Patient Access to Treatments Washington, D.C., Dec. 27, 2018 (GLOBE NEWSWIRE [...]

NeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable Technology

27/12/2018 - 19:30

WALTHAM, Mass., Dec. 27, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 10,159,835 titled “Detecting cutaneous electrode [...]

Ziopharm Oncology Responds to Recent Stock Decline and Clarifies Exclusivity Rights for Clinical Assets

27/12/2018 - 19:16

BOSTON, Dec. 27, 2018 (GLOBE NEWSWIRE) -- Ziopharm Oncology , Inc. (Nasdaq:ZIOP) today responded to the recent decline in the Company’s stock price, which accelerated greatly on December 26, 2018, the same day that the [...]

Digital Mental Health Startup headversity Launches Workplace Resilience Program

27/12/2018 - 18:00

CALGARY, Alberta, Dec. 27, 2018 (GLOBE NEWSWIRE) -- headversity, a digital mental health startup based out of Calgary, AB, has launched a Workplace Training program that builds and measures resiliency. PBA Land & [...]

Ossur Hf : Transactions in relation to share buyback program

27/12/2018 - 17:01

Announcement no. 73/2018 27 December 2018 Transactions in relation to share buyback program On 9 October 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2018. The purpose of the share [...]

Bio-Path Holdings Provides Clinical Update and 2019 Business Outlook

27/12/2018 - 14:49

HOUSTON, Dec. 27, 2018 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH), a biotechnology company leveraging its proprietary DNAbilize ® antisense RNAi nanoparticle technology to develop a portfolio of [...]

VistaGen Therapeutics to Present at 11th Annual Biotech Showcase

27/12/2018 - 14:30

SOUTH SAN FRANCISCO, Calif., Dec. 27, 2018 (GLOBE NEWSWIRE) -- VistaGen Therapeutics (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing new generation medicines for central nervous system (CNS) [...]

PSIQ Expects Strong Revenue Growth in 2019 as President Trump Signs Farm Bill Legalizing Hemp CBD Nationwide

27/12/2018 - 14:30

SUNRISE, Fla., Dec. 27, 2018 (GLOBE NEWSWIRE) -- Profile Solutions, Inc. (OTC Pink: PSIQ) announces based upon strong product demand for its Products, PSIQ is on the path toward significant revenue growth in 2019 as [...]

ICU Medical, Inc. to Present at the 37th J.P. Morgan Healthcare Conference

27/12/2018 - 14:00

SAN CLEMENTE, Calif., Dec. 27, 2018 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care [...]

Retrophin Doses First Patient in Pivotal Phase 3 PROTECT Study of Sparsentan for the Treatment of IgA Nephropathy

27/12/2018 - 14:00

SAN DIEGO, Dec. 27, 2018 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today announced that the first patient has been dosed in the PROTECT Study, a global, pivotal Phase 3 clinical trial evaluating the long-term [...]

MannKind Corporation to Hold Investor Conference Call

27/12/2018 - 14:00

- Scheduled for Friday, January 4, 2019 at 9 AM ET - WESTLAKE VILLAGE, Calif., Dec. 27, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD) will host a conference call on Friday, January 4, 2019 to discuss [...]

IBEX Grants Stock Options

27/12/2018 - 14:00

MONTREAL, Québec, Dec. 27, 2018 (GLOBE NEWSWIRE) -- IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX Venture: IBT) announces that on December 22, 2018, its Board of Directors granted 300,000 stock options to its [...]

NanoVibronix Announces Expanded Agreement with MDS Pharm Ltd. to Include Distribution of UroShield® in Israel

27/12/2018 - 14:00

ELMSFORD, N.Y., Dec. 27, 2018 (GLOBE NEWSWIRE) -- NanoVibronix, Inc., (NASDAQ: NAOV) , a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW) technology, [...]

BrainStorm Issues 2018 Letter to Shareholders

27/12/2018 - 13:35

NEW YORK, Dec. 27, 2018 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today issued a Letter to shareholders. [...]

BeyondSpring Announces Positive Pre-NDA Meeting with the U.S. FDA for its Lead Asset, Plinabulin

27/12/2018 - 13:30

Company On Track to Submit New Drug Applications for Non-Small Cell Lung Cancer and Chemotherapy-Induced Neutropenia in the United States and China NEW YORK, Dec. 27, 2018 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: [...]